Literature DB >> 24274180

Thyroid cancer.

Tobias Carling1, Robert Udelsman.   

Abstract

Thyroid cancer is rapidly increasing in incidence, but the mortality rate remains flat. Debate has arisen over the need to detect or treat most thyroid cancers early, given their favorable natural history. The appropriate extent of surgery for thyroid cancer is also controversial: some researchers advocate partial and others total thyroidectomy; some advocate prophylactic central cervical lymph node dissection, whereas others only rarely recommend lymphadenectomy. Although radioactive iodine is effective, its appropriate use and dosage remain controversial. In addition, molecular analysis of thyroid cancer is frequently used for diagnostic purposes involving preoperative fine-needle biopsy specimens as well as to define targetable pathways altered in the disease to guide clinical trials of drug therapy for advanced thyroid cancers.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24274180     DOI: 10.1146/annurev-med-061512-105739

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  103 in total

1.  The 8q24 rs6983267G variant is associated with increased thyroid cancer risk.

Authors:  Ruta Sahasrabudhe; Ana Estrada; Paul Lott; Lynn Martin; Guadalupe Polanco Echeverry; Alejandro Velez; Gila Neta; Meiko Takahasi; Vladimir Saenko; Norisato Mitsutake; Emma Jaeguer; Carlos Simon Duque; Alejandro Rios; Mabel Bohorquez; Rodrigo Prieto; Angel Criollo; Magdalena Echeverry; Ian Tomlinson; Luis G Carvajal Carmona
Journal:  Endocr Relat Cancer       Date:  2015-08-19       Impact factor: 5.678

2.  Distribution patterns of microcalcifications in suspected thyroid carcinoma: a classification method helpful for diagnosis.

Authors:  Chun-Ping Ning; Qing-Lian Ji; Shi-Bao Fang; Hong-Qiao Wang; Yan-Mi Zhong; Hai-Tao Niu
Journal:  Eur Radiol       Date:  2018-01-08       Impact factor: 5.315

3.  Overexpression miR-211-5p hinders the proliferation, migration, and invasion of thyroid tumor cells by downregulating SOX11.

Authors:  Lei Wang; Yan-Feng Shen; Zhi-Min Shi; Xiao-Juan Shang; Dong-Ling Jin; Feng Xi
Journal:  J Clin Lab Anal       Date:  2017-07-13       Impact factor: 2.352

4.  Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an IL-8-Akt-Slug pathway.

Authors:  C Visciano; F Liotti; N Prevete; G Cali'; R Franco; F Collina; A de Paulis; G Marone; M Santoro; R M Melillo
Journal:  Oncogene       Date:  2015-01-26       Impact factor: 9.867

5.  Limitation of intraoperative frozen section during thyroid surgery.

Authors:  Sandrine Estebe; Cecile Montenat; Adrien Tremoureux; Chloé Rousseau; François Bouilloud; Franck Jegoux
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-12-02       Impact factor: 2.503

6.  Dysbiosis of the gut microbiome is associated with thyroid cancer and thyroid nodules and correlated with clinical index of thyroid function.

Authors:  Jiaming Zhang; Fanghua Zhang; Changying Zhao; Qian Xu; Cheng Liang; Ying Yang; Huiling Wang; Yongfang Shang; Ye Wang; Xiaofeng Mu; Dequan Zhu; Chunling Zhang; Junjie Yang; Minxiu Yao; Lei Zhang
Journal:  Endocrine       Date:  2018-12-24       Impact factor: 3.633

7.  Heterogenous nature of gene expression patterns in BRAF-like papillary thyroid carcinomas with BRAFV600E.

Authors:  Yuji Nagayama; Hiroyuki Mishima
Journal:  Endocrine       Date:  2019-09-02       Impact factor: 3.633

Review 8.  The immune network in thyroid cancer.

Authors:  Maria Rosaria Galdiero; Gilda Varricchi; Gianni Marone
Journal:  Oncoimmunology       Date:  2016-03-30       Impact factor: 8.110

9.  LncRNA PTCSC3 affects drug resistance of anaplastic thyroid cancer through STAT3/INO80 pathway.

Authors:  Xiao-Ming Wang; Yang Liu; Yu-Xia Fan; Zheng Liu; Qing-Ling Yuan; Meng Jia; Zu-Shi Geng; Ling Gu; Xiu-Bo Lu
Journal:  Cancer Biol Ther       Date:  2018-05-03       Impact factor: 4.742

Review 10.  Current Standards in Treatment of Radioiodine Refractory Thyroid Cancer.

Authors:  Sujata Narayanan; A Dimitrios Colevas
Journal:  Curr Treat Options Oncol       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.